Survival of Head and Neck Cancer Cells Relies upon LZK Kinase-Mediated Stabilization of Mutant p53
Head and neck squamous cell carcinoma (HNSCC) includes epithelial cancers of the oral and nasal cavity, larynx, and pharynx and accounts for ∼350,000 deaths per year worldwide. Smoking-related HNSCC is associated with few targetable mutations but is defined by frequent copy-number alteration, the most common of which is gain at 3q. Critical 3q target genes have not been conclusively determined for HNSCC. Here, we present data indicating that MAP3K13 (encoding LZK) is an amplified driver gene in HNSCC. Copy-number gain at 3q resulted in increased MAP3K13 mRNA in HNSCC tumor samples and cell lines. Silencing LZK reduced cell viability and proliferation of HNSCC cells with 3q gain but not control cell lines. Inducible silencing of LZK caused near-complete loss of colony-forming ability in cells harboring 3q gain. These results were validated in vivo by evidence that LZK silencing was sufficient to reduce tumor growth in a xenograft model of HNSCC. Our results establish LZK as critical for maintaining expression of mutant stabilized p53. Cancer Res; 77(18); 4961–72. ©2017 AACR.
Source: Cancer Research - Category: Cancer & Oncology Authors: Zoe C. Edwards, Eleanor W. Trotter, Pedro Torres-Ayuso, Phil Chapman, Henry M. Wood, Katherine Nyswaner, John Brognard Tags: Tumor and Stem Cell Biology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Carcinoma | Cytology | Epithelial Cancer | Genetics | Head and Neck Cancer | HNSCC | Laryngeal Cancer | Nasal Cavity and Paranasal Sinus Cancer | Oral Cancer | Pharyngeal Cancer | Skin Cancer | Smokers | Squamous Cell Carcinoma | Stem Cell Therapy | Stem Cells